Home › Cases › Confused, Anaemic, Platelets of 12
TTP
Confused, Anaemic, Platelets of 12
6 questions
Question 1 · Putting It Together
Correct answer: Thrombotic thrombocytopaenic purpura — microangiopathic haemolytic anaemia with thrombocytopaenia
Why
MAHA plus thrombocytopaenia is TTP until proven otherwise.
- MAHA: schistocytes on the film, Hb <100, raised LDH, low haptoglobin, raised bilirubin, raised reticulocytes
- Thrombocytopaenia, typically <30 × 10⁹/L
- The classic pentad adds neurological features, fever and renal impairment — but it is not always complete, and MAHA plus thrombocytopaenia alone warrants urgent treatment
- ITP does not cause haemolysis or schistocytes
- A negative Coombs is the point — it tells you this is mechanical, not immune, haemolysis
Key point
MAHA + thrombocytopaenia = treat as TTP. Do not wait for the full pentad; it is often incomplete.
Question 2 · The Film
Correct answer: A blood film for schistocytes is an emergency — call haematology the same day
Why
A blood film for schistocytes is an emergency — call haematology the same day. The pathway states it in those terms.
- Schistocytes are the morphological evidence of mechanical red cell destruction in the microvasculature, and they are what distinguishes a thrombotic microangiopathy from the alternatives
- Waiting for routine reporting can cost a day, and plasma exchange must start within 4–8 hours of diagnosis
- The biochemistry supports haemolysis but does not tell you it is microangiopathic — the film does
Key point
The film is an emergency test. Biochemistry says haemolysis; only the film says microangiopathic.
Question 3 · The Confirmatory Test
Correct answer: ADAMTS13 activity <10% — and it must be sent before the first plasma exchange
Why
ADAMTS13 activity <10% confirms TTP, and it must be sent BEFORE the first plasma exchange.
- Exchange replaces the patient's plasma, so a sample taken afterwards no longer reflects their own ADAMTS13 activity — the diagnostic window closes the moment treatment starts
- Send the ADAMTS13 inhibitor titre at the same time
- Critically: do not delay plasma exchange waiting for the result if clinical suspicion is high. Send it, then treat
- Bone marrow examination has no role in the acute diagnosis of TTP
Key point
Send ADAMTS13 before the first exchange — but never delay the exchange for the result.
Question 4 · The Treatment
Correct answer: Plasma exchange — 1.5x plasma volume daily with FFP replacement, started within 4–8 hours of diagnosis
Why
Plasma exchange: 1.5x plasma volume daily, using FFP as the replacement fluid, started within 4–8 hours of diagnosis.
- Exchange does two things at once — it supplies functional ADAMTS13 and removes the autoantibody inhibiting it
- Continue daily until platelets exceed 150 × 10⁹/L for two consecutive days and LDH is normalising
- Coordinate with haematology and the ITU or apheresis unit early; the logistics are usually the rate-limiting step
- FFP infusion alone supplies ADAMTS13 but does not remove the inhibitor — it is a holding measure at best, never the plan
- IVIg is not the treatment for TTP
Key point
Plasma exchange within 4–8 hours. It supplies ADAMTS13 *and* removes the inhibitor — infusion alone does only half.
Question 5 · What Goes With It
Correct answer: Prednisolone 1mg/kg/day, maximum 60mg, and folic acid 5mg daily
Why
Prednisolone 1mg/kg/day (max 60mg) orally from diagnosis, continued until platelet remission then weaned. It reduces autoantibody production.
- Folic acid 5mg daily is supportive — haemolysis places a heavy demand on folate stores
- Caplacizumab is started alongside the first exchange where anti-vWF therapy is available: 10mg IV before the first exchange, then 10mg SC daily after each exchange, continued for 30 days after the last exchange
- Monitor glucose and blood pressure on high-dose steroid
- Platelet transfusion is contraindicated — the subject of the next case
Key point
Prednisolone 1mg/kg from diagnosis, plus folic acid. Caplacizumab alongside the first exchange where available.
Question 6 · Monitoring
Correct answer: Daily FBC, LDH and blood film; target platelets >150 × 10⁹/L, normal LDH, no neurological features
Why
Daily FBC, LDH and blood film.
- Target: platelets >150 × 10⁹/L, LDH normal, and no neurological features
- Exchange continues daily until the platelet count has been above 150 for two consecutive days with the LDH normalising
- Watch for exacerbation within 30 days of stopping exchange — recheck ADAMTS13
- Daily ADAMTS13 is not the monitoring test — it is slow to return and is used for diagnosis and for relapse assessment
- Weekly bloods would be far too infrequent in a condition that can deteriorate within hours
Key point
Daily FBC, LDH and film. Stop exchange after platelets >150 for two consecutive days — then watch for exacerbation.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.